Natural history, reasons for, and impact of low/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study.

作者: E. M. Clark , V. C. Gould , J. H. Tobias , R. Horne

DOI: 10.1007/S00198-015-3271-2

关键词:

摘要: Approximately 15 % of older women on oral medications for osteoporosis could be considered alternatives including parenteral therapies. Collection data socio-demographic/clinical variables is unlikely to helpful in predicting low/non-adherence. Alternative approaches are needed identify individuals at risk This study aims individual patient reasons stopping osteoporosis, and investigate whether this can predicted from knowledge about data, or alternative need used. The Cohort Skeletal Health Bristol Avon (COSHIBA) recruited 3200 South West UK, whom a proportion were baseline. Information self-reported adherence low/non-adherence collected 6-monthly intervals over 2-year period. Data was also potential predictors impact Two hundred thirty-three (7.3 %) Mean length time treatment prior enrolment 46 months. Of those medications, 94.9 % bisphosphonates; 8.5 % reported low 21.6 % stopped their medication completely the follow-up Length baseline did not influence rates Reasons bisphosphonates included side effects (53.9 %), practical such as forgetting take them (18.0 %) beliefs (20.5 %). No convincing identified. has important implications healthcare provision. medications.

参考文章(31)
Jeffrey R Curtis, Huifeng Yun, Robert Matthews, Kenneth G. Saag, Elizabeth Delzell, Adherence with intravenous zoledronate and intravenous ibandronate in the United States medicare population Arthritis Care and Research. ,vol. 64, pp. 1054- 1060 ,(2012) , 10.1002/ACR.21638
Helene M. Devold, Kari Furu, Svetlana Skurtveit, Aage Tverdal, Jan A. Falch, Anne Johanne Sogaard, Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway. Pharmacoepidemiology and Drug Safety. ,vol. 21, pp. 297- 304 ,(2012) , 10.1002/PDS.2344
Emma M Clark, Andy Ness, Jon H Tobias, Social position affects bone mass in childhood through opposing actions on height and weight. Journal of Bone and Mineral Research. ,vol. 20, pp. 2082- 2089 ,(2005) , 10.1359/JBMR.050808
Antonella Zambon, Gianluca Baio, Giampiero Mazzaglia, Luca Merlino, Giovanni Corrao, Discontinuity and failures of therapy with bisphosphonates: joint assessment of predictors with multi-state models. Pharmacoepidemiology and Drug Safety. ,vol. 17, pp. 260- 269 ,(2008) , 10.1002/PDS.1530
Davide Tassinari, Barbara Poggi, Stefania Nicoletti, Manuela Fantini, Emiliano Tamburini, Cinzia Possenti, Sergio Sartori, Zoledronic Acid Treatment at Home: Safety Data from an Observational Prospective Trial Journal of Palliative Medicine. ,vol. 10, pp. 352- 358 ,(2007) , 10.1089/JPM.2006.0122
Job F. M. van Boven, Pieter T. de Boer, Maarten J. Postma, Stefan Vegter, Persistence with osteoporosis medication among newly-treated osteoporotic patients Journal of Bone and Mineral Metabolism. ,vol. 31, pp. 562- 570 ,(2013) , 10.1007/S00774-013-0440-2
V. Cooper, G. Gellaitry, M. Hankins, M. Fisher, R. Horne, The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): a six-month prospective, follow-up study. Aids Care-psychological and Socio-medical Aspects of Aids\/hiv. ,vol. 21, pp. 520- 528 ,(2009) , 10.1080/09540120802301824
Golding, Pembrey, Jones, The Alspac Study Team, ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatric and Perinatal Epidemiology. ,vol. 15, pp. 74- 87 ,(2001) , 10.1046/J.1365-3016.2001.00325.X
Rachel A. Elliott, Nick Barber, Sarah Clifford, Robert Horne, Elaine Hartley, The cost effectiveness of a telephone-based pharmacy advisory service to improve adherence to newly prescribed medicines Pharmacy World & Science. ,vol. 30, pp. 17- 23 ,(2007) , 10.1007/S11096-007-9134-Y